Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SMD Rise PCLBKK:SMD100-R 60 Price-to-Tangible-Book is 1.79 as of Aug. 11, 2026, which is 21% above its 10-year median of 1.48. GuruFocus rates BKK:SMD100-R with a GF Score™ of 60/100 and a GF Value™ of ฿22.19. The stock has 6 warning signs investors should review. Among 102 Medical Distribution companies, SMD Rise PCL ranks better than 93.14% on this metric.
The historical rank and industry rank for SMD Rise PCL's Price-to-Tangible-Book or its related term are showing as below:
BKK:SMD100-R'
s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.35 Med: 1.48 Max: 3.69
Current: 0.35
During the past 8 years, SMD Rise PCL's highest Price to Tangible Book Ratio was 3.69. The lowest was 0.35. And the median was 1.48.
BKK:SMD100-R's Price-to-Tangible-Book is ranked better than 93.14% of 102
companies
in the Medical Distribution industry
Industry Median: 1.125
vs BKK:SMD100-R: 0.35
Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.
SMD Rise PCL Price-to-Tangible-Book Related Terms
SMD Rise PCL Price-to-Tangible-Book Historical Data
* Premium members only.
The historical data trend for SMD Rise PCL's Price-to-Tangible-Book can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:SMD100-R vs MCK, COR, CAH: Price-to-Tangible-Book Comparison
For the Medical Distribution subindustry, SMD Rise PCL's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SMD Rise PCL Price-to-Tangible-Book vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, SMD Rise PCL's Price-to-Tangible-Book distribution charts can be found below:
* The bar in red indicates where SMD Rise PCL's Price-to-Tangible-Book falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.
SMD Rise PCL (BKK:SMD100-R) has a Price-to-Tangible-Book of 1.79 as of Aug. 11, 2026. Price-to-tangible-book ratio is the ratio of share price to a company's tangible book value per share. View historical data on SMD Rise PCL and its competitors. This is 21% above median its historical median of 1.48. Over the past decade, SMD Rise PCL's Price-to-Tangible-Book has ranged from 0.35 to 3.69. According to the industry distribution chart, SMD Rise PCL ranks #7 out of 102 companies in the Medical Distribution industry, placing it in the top 6.9%.
Is SMD Rise PCL's Price-to-Tangible-Book too high?
SMD Rise PCL's current Price-to-Tangible-Book of 1.79 is 21% above median its 10-year median of 1.48. Over the past 10 years, this metric has ranged from a low of 0.35 to a high of 3.69. The Medical Distribution industry median Price-to-Tangible-Book is 1.13. SMD Rise PCL's value of 1.79 is 59.1% above this industry median. Based on the distribution chart, SMD Rise PCL ranks #7 out of 102 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, SMD Rise PCL has a GF Score™ of 60/100, reflecting its overall financial health beyond just this single metric.
How does SMD Rise PCL's Price-to-Tangible-Book compare to MCK and COR?
According to the Medical Distribution industry distribution chart, SMD Rise PCL ranks #7 out of 102 companies for Price-to-Tangible-Book. This places SMD Rise PCL in the top 7% of its industry — outperforming the majority of peers. The industry median Price-to-Tangible-Book is 1.13. SMD Rise PCL's value of 1.79 is 59.1% above this benchmark. Historically, SMD Rise PCL's own Price-to-Tangible-Book has ranged from 0.35 to 3.69 over the past decade. While the company's 10-year median is 1.48 vs. the industry median of 1.13, SMD Rise PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Price-to-Tangible-Book for a Medical Distribution company?
The median Price-to-Tangible-Book among Medical Distribution companies is 1.13, based on 102 companies in the industry. Companies in the top quartile (top 25%) have a Price-to-Tangible-Book significantly above this median, while those in the bottom quartile fall well below. However, Price-to-Tangible-Book should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SMD Rise PCL's current Price-to-Tangible-Book of 1.79 is 59.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Price-to-Tangible-Book mean?
A high Price-to-Tangible-Book can signal that a stock is expensive relative to its fundamentals. Price-to-tangible-book ratio is the ratio of share price to a company's tangible book value per share. View historical data on SMD Rise PCL and its competitors. For the Medical Distribution industry, the median Price-to-Tangible-Book is 1.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SMD Rise PCL's current Price-to-Tangible-Book is 1.79, which is 21% above median its own 10-year median of 1.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SMD Rise PCL stock overvalued right now?
SMD Rise PCL (BKK:SMD100-R) has a current Price-to-Tangible-Book of 1.79. The stock's GF Value™ is ฿22.19, compared to a current price of ฿5.85 — trading 73.6% below its estimated fair value. The current Price-to-Tangible-Book is 1.79, which is 21% above median its 10-year median of 1.48 and 59.1% above the Medical Distribution industry median of 1.13. SMD Rise PCL's overall GF Score™ is 60/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Price-to-Tangible-Book calculated?
Price-to-Tangible-Book is calculated from a company's financial statements. For SMD Rise PCL (BKK:SMD100-R), the current Price-to-Tangible-Book is 1.79 as of Aug. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SMD Rise PCL (BKK:SMD100-R) Overvalued in 2026?
Based on GuruFocus' analysis, SMD Rise PCL stock appears to be undervalued.
The current stock price of ฿5.85 is trading 73.6% below its estimated GF Value™ of ฿22.19.
Key valuation signals for BKK:SMD100-R:
Price-to-Tangible-Book: 1.79 (21% above median its 10-year median of 1.48)
GF Value™: ฿22.19 vs. price of ฿5.85 (73.6% below fair value)
Industry Position: 59.1% above the Medical Distribution median (#7 of 102)
No single metric tells the full story. See the BKK:SMD100-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Address222,222/1-2 Moo 1, Rattanathibet Road, West Inn Complex Building, 10th Floor, Bang Rak Yai Subdistrict, Bang Bua Thong District, Nonthaburi Province, Bangkok, THA, 11110
SMD Rise PCL, formerly Saintmed PCL is engaged in the import and distribution of medical devices and equipment, rental services for medical equipment, and providing services related to medical equipment. It operates in Thailand. The Group is engaged in three operating segments: Sale of medical devices and equipment, medical supplies, Services of medical equipment at sleep lab centers and repair services, and Revenue from rental of medical equipment at wellness centers and other services. The Group is managed and operates principally in Thailand.
60GF Score
Get the complete analysis for BKK:SMD100-R
Price-to-Tangible-Book is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:SMD100-R has been successfully added to your 
